HomeNewsPoliticsOmicron is currently dominant COVID-19 variant in India: Govt

Omicron is currently dominant COVID-19 variant in India: Govt

With the reporting of Omicron, a highly mutated variant of SARSCoV-2 virus and its classification as a Variant of Concern (VoC) by the World Health Organization (WHO), the Union Ministry of Health revised its 'Guidelines for international arrivals', Mansukh Mandaviya said in a written reply.

February 08, 2022 / 17:30 IST
Story continues below Advertisement
Union Health Minister Mansukh Mandaviya. (File image)
Union Health Minister Mansukh Mandaviya. (File image)

Omicron variant is the dominant variant in the country presently and the current surge of COVID-19 cases in the country is showing a sustained declining trend since January 21, Union Health Minister Mansukh Mandaviya informed the Rajya Sabha on Tuesday.

With the reporting of Omicron, a highly mutated variant of SARSCoV-2 virus and its classification as a Variant of Concern (VoC) by the World Health Organization (WHO), the Union Ministry of Health revised its 'Guidelines for international arrivals', Mandaviya said in a written reply.

Story continues below Advertisement

"Omicron variant is the dominant variant in the country presently. The current surge of COVID-19 cases in the country is showing a sustained declining trend since January 21, 2022,” he said.

Following a risk based approach, provisions for mandatory pre-departure and post arrival RT-PCR testing on day 8th of arrival and a mandatory home quarantine for 7 days have been made in the present guidelines for all international travellers to India.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show